A Study to Investigate the Potential Pharmacokinetic Interaction Between TMC435 and Methadone

Summary

The purpose of this study is to evaluate the effect of steady-state (constant concentration of medication in the blood) TMC435 (150 mg, once a day) on the steady state pharmacokinetics (what the body does to the medication) of R- and S-methadone.

Timeline

Start

2009-09

Primary completion

2010-01

Completion

2010-01

Drugs

Indications